It’s not long enough to burst any bubbles (yet), but Mathew V Kiang, and ProfessorKeith Humphreys of Stanford University present a striking conclusion: US reductions in overdose deaths might have just been a detour from the pandemic’s acceleration, not a change in trajectory from 2019.


